7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Telomir Pharmaceuticals
(NASDAQ:TELO) 


Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.

Founded: 2021
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
No extra charts and metrics for this ticker.